Can Gallbladder Removal Cause Insulin Resistance?

Gallbladder removal, known medically as cholecystectomy, appears to raise the risk of insulin resistance, though the relationship is more tangled than a simple cause-and-effect. Cross-sectional and prospective studies show that people who have had their gallbladder taken out carry meaningfully higher odds of prediabetes and diabetes, even after accounting for weight and other risk factors. The mechanism runs through bile acid signaling, which turns out to play a surprisingly large role in how your body handles blood sugar.

What the Epidemiological Evidence Shows

The most direct evidence comes from studies that tracked blood sugar markers before and after surgery, or compared people with and without a gallbladder. In one prospective study, people who had undergone cholecystectomy had roughly three times the odds of prediabetes and five times the odds of diabetes compared to those with intact gallbladders, after adjusting for age, sex, body weight, and other factors.¹ Those are striking numbers. Over a follow-up of about three years, the cholecystectomy group was also more likely to see meaningful jumps in fasting blood sugar and HbA1c, a marker of average blood sugar over the preceding months. The adjusted odds of a 10% or greater rise in HbA1c were about two and a half times higher in the surgery group.¹

These numbers deserve a caveat. People who need gallbladder surgery tend to already carry metabolic risk factors like obesity and high triglycerides, both of which independently drive insulin resistance. Still, the fact that the association holds even after adjusting for body weight and baseline blood sugar status suggests something beyond shared risk factors is going on. Cholecystectomy has been increasingly recognized as an independent risk factor for metabolic syndrome, fatty liver disease, and type 2 diabetes.²

Why Bile Acid Signaling Matters for Blood Sugar

Your gallbladder is basically a storage tank for bile acids, the digestive molecules your liver produces to break down fats. When you eat, the gallbladder squeezes concentrated bile into the small intestine in a well-timed pulse. Once the gallbladder is gone, bile trickles continuously from the liver into the intestine instead of arriving in that concentrated, meal-triggered burst.

This matters far more than you might expect, because bile acids are not just detergent for fat. They also act as signaling molecules. Two receptors in particular, called FXR and TGR5, respond to bile acids and help regulate blood sugar. FXR activation in the gut influences how the liver produces glucose and stores fat. TGR5 has a more direct role: when bile acids activate it in the intestinal lining, it triggers the release of GLP-1, a hormone that tells the pancreas to produce insulin.³ This is the same pathway that GLP-1 receptor agonist drugs like semaglutide are designed to exploit, so its importance for metabolic health is well established.

Animal studies have demonstrated that TGR5 signaling controls GLP-1 release and improves glucose tolerance in obese subjects, confirming that this is not just a theoretical pathway.⁴ When the gallbladder is removed, the pattern of bile acid delivery changes. Rather than a concentrated pulse after meals, bile acids reach the gut in a dilute, continuous drip. This alters the timing and concentration of the signals reaching FXR and TGR5, and disruption of the FXR pathway also reduces levels of fibroblast growth factor 19 (FGF19), a hormone produced in the gut that helps the liver regulate its own bile acid production and glucose metabolism.²

A Surprising Wrinkle in GLP-1 Response

If bile acid signaling is disrupted, you might expect GLP-1 levels to plummet after gallbladder removal. But at least one controlled study found something more nuanced: cholecystectomized subjects did have reduced bile acid concentrations in the upper intestine after a meal, yet their blood levels of GLP-1 were not significantly different from those of people with intact gallbladders.⁵ The researchers concluded that gallbladder emptying is not strictly required for GLP-1 release. The continuous trickle of bile may stimulate GLP-1 production further down the intestine, or other triggers for GLP-1 release, like nutrients contacting the gut lining, may compensate.

This finding complicates the story. It suggests the insulin resistance seen after cholecystectomy is not driven purely by reduced GLP-1, and that other disrupted pathways, particularly FXR signaling, changes in bile acid composition, and downstream effects on the liver and gut microbiome, are likely doing more of the metabolic damage. It also hints that different people may compensate differently for the loss of their gallbladder, which could partly explain why some individuals develop clear metabolic problems after surgery while others do not.

There is also an opposite and somewhat paradoxical situation seen in certain bariatric surgery patients. After Roux-en-Y gastric bypass, bile acid levels can become elevated, leading to exaggerated GLP-1 and insulin responses that actually cause postprandial hypoglycemia, where blood sugar crashes too low after eating.⁶ Reports of a similar pattern after cholecystectomy itself are rare, but case reports of cholecystectomy-associated postprandial hypoglycemia have been documented, with researchers proposing that altered bile acid kinetics stimulate excessive GLP-1 and insulin surges in some individuals.⁷ So gallbladder removal doesn’t always push blood sugar in one direction. In most people the trend leans toward insulin resistance and higher glucose, but in a few the disrupted signaling produces the opposite problem.

The Fatty Liver Connection

One of the clearest downstream consequences of gallbladder removal is an increased risk of fatty liver disease, and fatty liver is itself one of the most potent drivers of insulin resistance. A large meta-analysis pooling data from studies covering 27 million individuals found that cholecystectomy was associated with a 54% increased risk of nonalcoholic fatty liver disease.⁸ That is a robust signal across a very large dataset.

The link between gallbladder removal and fatty liver likely works through several channels. Without the gallbladder’s regulated bile release, the liver’s own fat metabolism changes. Bile acids normally help the liver break down and export fat through the signaling pathways described above. When those signals are weakened or mistimed, fat accumulates in liver cells. Emerging research continues to reinforce this connection, with newer studies specifically framing it as a development that clinicians should anticipate after surgery.⁹

The risk appears to multiply when a person already has other cardiometabolic risk factors. A cohort study stratified by the number of existing risk factors found that the risk of developing fatty liver disease was dramatically higher, roughly five times the baseline rate in the fully adjusted model, for people who had both a cholecystectomy and three or more cardiometabolic risk factors like high blood pressure, elevated triglycerides, or obesity.⁸ By contrast, cholecystectomy in people with few other risk factors carried a much smaller and statistically uncertain additional risk. This is a meaningful distinction: it suggests gallbladder removal amplifies existing metabolic vulnerability rather than creating it from scratch.

Gut Microbiome Shifts After Surgery

The continuous flow of bile into the intestine after cholecystectomy changes the chemical environment your gut bacteria live in, and this appears to reshape the microbial community in ways that affect metabolism. Research comparing the gut microbiomes of people with and without diarrhea after gallbladder surgery found that those with post-cholecystectomy symptoms had notably lower abundances of bacterial species involved in lipid metabolism pathways.¹⁰ Other researchers have noted that disrupted bile flow after gallbladder removal can lead to gut microbial imbalances that further impair glucose metabolism.¹¹

This adds another layer to the mechanism. Gut bacteria metabolize primary bile acids into secondary bile acids, which have their own effects on FXR and TGR5 signaling. When the microbial community is disrupted, the balance of primary and secondary bile acids shifts, and downstream metabolic signaling shifts with it. Whether these microbiome changes are a major independent driver of insulin resistance or just one more contributor in a cascade is not yet settled, but the evidence is pointing toward a genuine and underappreciated role.

What Happens in the Months After Surgery

One six-month prospective study tracking metabolic markers after cholecystectomy found a somewhat mixed picture. Body mass index and fasting blood sugar actually dropped over the first six months, which sounds like good news.¹² But blood pressure rose, and HbA1c, triglycerides, and HDL cholesterol did not change meaningfully. The fasting blood sugar drop may reflect dietary changes in the immediate recovery period, when many people eat less fat and fewer calories, rather than a genuine metabolic improvement.

The longer-term data from multi-year follow-ups paints a different picture, as noted in the dysglycemia study where worsening blood sugar markers became apparent over roughly three years.¹ This suggests that the metabolic consequences of gallbladder removal develop gradually as the body’s compensatory mechanisms wear down or as secondary effects like liver fat accumulation take hold. If you have recently had your gallbladder removed and your blood sugar numbers look fine at three months, that does not mean you are in the clear indefinitely.

Sex Differences and Who Faces Higher Risk

Gallbladder disease itself is more common in women, and the metabolic consequences of surgery may differ by sex as well. A large population-based cohort study found that obesity had a stronger association with cholecystectomy risk in women than in men, and that hormonal factors, specifically low sex hormone-binding globulin (SHBG) and elevated testosterone, were linked to higher cholecystectomy risk in women but not consistently in men.¹³ Since low SHBG and elevated testosterone are themselves markers of insulin resistance (they are core features of polycystic ovary syndrome), this creates a feedback loop: the same metabolic profile that leads to gallstone formation and surgery may be the profile most vulnerable to metabolic worsening afterward.

This doesn’t mean men are unaffected. The bile acid signaling disruption operates regardless of sex. But the higher baseline prevalence of gallbladder disease in women, combined with hormonal factors that overlap with insulin resistance, means women who undergo cholecystectomy may deserve closer metabolic monitoring in the years following surgery.

Separating What Surgery Does from What Was Already There

The central challenge in this field is untangling causation from correlation. People who develop gallstones severe enough to need surgery typically already have obesity, high cholesterol, insulin resistance, or some combination. Those conditions are themselves the classic precursors to type 2 diabetes. When researchers find higher rates of diabetes in cholecystectomized individuals, how much is the surgery’s fault and how much was baked in before anyone picked up a scalpel?

The best available evidence suggests both are true. The shared risk factors account for a large chunk of the association, but the surgery appears to add its own independent contribution. Studies that adjust for baseline weight, blood sugar, and metabolic status still find elevated odds of glycemic deterioration in the cholecystectomy group.¹ The biological plausibility is strong: bile acid signaling genuinely does regulate glucose metabolism, and removing the organ that controls bile acid delivery genuinely does alter that signaling. And the fatty liver data adds a concrete intermediary, a measurable physiological change that connects gallbladder removal to worsening insulin sensitivity.

None of this means you should refuse gallbladder surgery if you need it. Gallstones can cause serious complications including pancreatitis and biliary sepsis, and cholecystectomy is one of the most common and safest surgeries performed worldwide. The metabolic risk is real but incremental, and for most people it is manageable with awareness and monitoring.

Monitoring and Practical Steps After Surgery

If you have had your gallbladder removed, or are about to, there are a few concrete things worth doing. First, consider asking your doctor for periodic fasting glucose and HbA1c checks in the years after surgery, even if your numbers were normal beforehand. The evidence suggests metabolic changes can emerge gradually, and catching a drift toward prediabetes early gives you far more options than catching it late.

Second, the multiplier effect with other cardiometabolic risk factors is worth paying attention to. If you already carry excess weight, have elevated blood pressure or triglycerides, or have a family history of type 2 diabetes, gallbladder removal shifts you into a higher-risk category for fatty liver disease and insulin resistance. Addressing those modifiable factors, through diet, physical activity, and where appropriate medication, becomes more urgent after surgery, not less.

Researchers have begun exploring more targeted strategies. Bile acid sequestrants, drugs that bind bile acids in the gut and alter their signaling effects, are being investigated as a potential approach for people who develop glucose dysregulation after cholecystectomy.⁷ And given what we know about the FXR and TGR5 pathways, drugs that target these receptors could eventually offer more precise interventions. For now, though, these are research directions rather than clinical recommendations.

Why This Connection Took So Long to Recognize

Cholecystectomy has been performed for well over a century, and for most of that time the gallbladder was considered a fairly expendable organ. Surgeons sometimes described it as a simple storage bag for bile, and its removal was thought to have minimal long-term consequences beyond occasional loose stools. The idea that it played a meaningful role in metabolic regulation was not taken seriously until bile acids were recognized as signaling molecules in the early 2000s. Once researchers understood that bile acids activate FXR and TGR5 and thereby influence insulin, glucose, and fat metabolism, the gallbladder’s role as the regulator of bile acid delivery timing suddenly mattered a great deal.

This is part of a broader pattern in medicine where organs initially thought to be vestigial or minor, like the appendix or the tonsils, turn out to have functions that become apparent only after large numbers of people have had them removed and enough time has passed to track the consequences. The metabolic effects of cholecystectomy are real, but they are also subtle enough that they were invisible in the era before widespread metabolic syndrome and large longitudinal cohort studies. With obesity rates climbing and cholecystectomy remaining one of the most performed surgeries globally, the intersection of these two trends has made the metabolic consequences harder to ignore.

1
PubMed Central. Cholecystectomy is associated with dysglycaemia: Cross‐sectional and prospective analyses
2
PubMed Central. Cholecystectomy and risk of metabolic syndrome
3
PubMed Central. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation
4
PubMed Central. TGR5-mediated bile acid sensing controls glucose homeostasis
5
PubMed. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients
6
PubMed Central. Altered bile acid kinetics contribute to postprandial hypoglycaemia after Roux-en-Y gastric bypass surgery
7
AACE Endocrinology and Diabetes. Cholecystectomy-Associated Postprandial Hypoglycemia
8
PubMed Central. Cholecystectomy and risk of liver disease: a systematic review and meta-analysis of 27 million individuals
9
PubMed Central. Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications
10
PubMed Central. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea
11
The Journal of Clinical Endocrinology & Metabolism. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention
12
PubMed Central. Impact of cholecystectomy on Metabolic dysfunction-Associated Steatotic Liver Disease and metabolic syndrome: a 6-month prospective cohort study
13
PubMed Central. Sex-specific associations of SHBG, testosterone, and obesity with cholecystectomy risk: a population-based cohort study